格雷夫斯病骨折发生率:一项基于人群的研究
该回顾性队列研究纳入2134例新发格雷夫斯病患者和21261名年龄、性别及县匹配的对照,随访16-18年,评估骨折风险。格雷夫斯病患者接受骨质疏松治疗及糖皮质激素治疗的比例更高。
要点
- 格雷夫斯病与对照组总骨折率无显著差异。
- 格雷夫斯病患者接受骨质疏松治疗及糖皮质激素治疗的比例高于对照。
核心结论
- 格雷夫斯病与一般人群总骨折率无显著差异,但年龄>52岁男性格雷夫斯病患者椎体骨折率更高。
- 接受治疗的格雷夫斯病患者较一般人群接受更多骨质疏松治疗。
研究设计与样本
- 回顾性队列研究,纳入2134例新发格雷夫斯病患者和21261名年龄、性别及县匹配的对照,随访16-18年,使用瑞典国家登记数据库评估骨骼并发症风险。
主要发现
- 格雷夫斯病与对照组骨折率无显著差异。
- 格雷夫斯病患者接受骨质疏松治疗及糖皮质激素治疗的比例高于对照。
- 调整骨质疏松治疗及糖皮质激素治疗后,格雷夫斯病与骨折关联的HR基本不变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Population-based studies have indicated an increase in bone turnover in hyperthyroidism with a subsequent decrease in bone mineral density and an increased risk of fractures, especially in postmenopausal women. However, heterogeneity between studies prevents a definitive conclusion. Graves' disease (GD) is an autoimmune disease, and it is the most common cause of hyperthyroidism. The aim of this study was to investigate fracture risk in patients with GD. Methods: A total of 2134 patients with incident GD and 21,261 age, sex- and county-matched controls were included 16-18 years after diagnosis in a retrospective cohort study. Drug and patient national registries in Sweden were used to assess the risk of developing skeletal complications. Up to 10 years of age, sex- and county-matched controls per patient were selected from databases from the National Board of Health and Welfare and Statistics Sweden. Cox proportional hazards models were fitted to estimate hazard ratios (HR) and confidence intervals [CI]. Results: There were no significant differences in fracture rates between GD and controls but after adjustment for comorbidities, the data showed higher vertebral fracture rates in male GD patients aged >52 years compared to male controls, HR = 2.83 [CI 1.05-7.64]. The rates of osteoporosis treatments as well as treatment with corticosteroids were higher in patients with GD. However, HR for the association between GD and fractures remained largely unchanged after adjustment for osteoporosis treatments and treatments with corticosteroids. Conclusions: There were no significant differences in total fracture rate between GD and the general population. However, men older than 52 years had a higher vertebral fracture rate. This study also shows that patients with treated GD receive more osteoporosis treatments compared to the general population.
引用
- Khamisi S, Udumyan R, Sjölin G, et al. Fracture Incidence in Graves' Disease: A Population-Based Study. Thyroid. 2023. PMID: 37725590. doi:10.1089/thy.2023.0162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。